Search Results - "Neurology"

Global Epidemiology of Stroke and Access to Acute Ischemic Stroke Interventions by Saini, Vasu, Guada, Luis, Yavagal, Dileep R

“…To provide an up-to-date review of the incidence of stroke and large vessel occlusion (LVO) around the globe, as well as the eligibility and access to IV…”
Get full text

Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry by Romero-Sánchez, Carlos Manuel, Díaz-Maroto, Inmaculada, Fernández-Díaz, Eva, Sánchez-Larsen, Álvaro, Layos-Romero, Almudena, García-García, Jorge, González, Esther, Redondo-Peñas, Inmaculada, Perona-Moratalla, Ana Belén, Del Valle-Pérez, José Antonio, Gracia-Gil, Julia, Rojas-Bartolomé, Laura, Feria-Vilar, Inmaculada, Monteagudo, María, Palao, María, Palazón-García, Elena, Alcahut-Rodríguez, Cristian, Sopelana-Garay, David, Moreno, Yóscar, Ahmad, Javaad, Segura, Tomás

“…OBJECTIVEThe coronavirus disease 2019 (COVID-19) has spread worldwide since December 2019. Neurologic symptoms have been reported as part of the clinical…”
Get full text

Miller Fisher syndrome and polyneuritis cranialis in COVID-19 by Gutiérrez-Ortiz, Consuelo, Méndez-Guerrero, Antonio, Rodrigo-Rey, Sara, San Pedro-Murillo, Eduardo, Bermejo-Guerrero, Laura, Gordo-Mañas, Ricardo, de Aragón-Gómez, Fernando, Benito-León, Julián

“…To report 2 patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) who presented acutely with Miller Fisher syndrome and…”
Get full text

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium by McKeith, Ian G, Boeve, Bradley F, Dickson, Dennis W, Halliday, Glenda, Taylor, John-Paul, Weintraub, Daniel, Aarsland, Dag, Galvin, James, Attems, Johannes, Ballard, Clive G, Bayston, Ashley, Beach, Thomas G, Blanc, Frédéric, Bohnen, Nicolaas, Bonanni, Laura, Bras, Jose, Brundin, Patrik, Burn, David, Chen-Plotkin, Alice, Duda, John E, El-Agnaf, Omar, Feldman, Howard, Ferman, Tanis J, ffytche, Dominic, Fujishiro, Hiroshige, Galasko, Douglas, Goldman, Jennifer G, Gomperts, Stephen N, Graff-Radford, Neill R, Honig, Lawrence S, Iranzo, Alex, Kantarci, Kejal, Kaufer, Daniel, Kukull, Walter, Lee, Virginia M.Y, Leverenz, James B, Lewis, Simon, Lippa, Carol, Lunde, Angela, Masellis, Mario, Masliah, Eliezer, McLean, Pamela, Mollenhauer, Brit, Montine, Thomas J, Moreno, Emilio, Mori, Etsuro, Murray, Melissa, OʼBrien, John T, Orimo, Sotoshi, Postuma, Ronald B, Ramaswamy, Shankar, Ross, Owen A, Salmon, David P, Singleton, Andrew, Taylor, Angela, Thomas, Alan, Tiraboschi, Pietro, Toledo, Jon B, Trojanowski, John Q, Tsuang, Debby, Walker, Zuzana, Yamada, Masahito, Kosaka, Kenji

“…The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about the clinical and pathologic diagnosis of DLB, updating the previous…”
Get full text

The prevalence of MS in the United States: A population-based estimate using health claims data by Wallin, Mitchell T, Culpepper, William J, Campbell, Jonathan D, Nelson, Lorene M, Langer-Gould, Annette, Marrie, Ruth Ann, Cutter, Gary R, Kaye, Wendy E, Wagner, Laurie, Tremlett, Helen, Buka, Stephen L, Dilokthornsakul, Piyameth, Topol, Barbara, Chen, Lie H, LaRocca, Nicholas G

“…OBJECTIVETo generate a national multiple sclerosis (MS) prevalence estimate for the United States by applying a validated algorithm to multiple administrative…”
Get full text

High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis by Schindler, Suzanne E, Bollinger, James G, Ovod, Vitaliy, Mawuenyega, Kwasi G, Li, Yan, Gordon, Brian A, Holtzman, David M, Morris, John C, Benzinger, Tammie L.S, Xiong, Chengjie, Fagan, Anne M, Bateman, Randall J

“…OBJECTIVEWe examined whether plasma β-amyloid (Aβ)42/Aβ40, as measured by a high-precision assay, accurately diagnosed brain amyloidosis using amyloid PET or…”
Get full text

Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology by Petersen, Ronald C, Lopez, Oscar, Armstrong, Melissa J, Getchius, Thomas S.D, Ganguli, Mary, Gloss, David, Gronseth, Gary S, Marson, Daniel, Pringsheim, Tamara, Day, Gregory S, Sager, Mark, Stevens, James, Rae-Grant, Alexander

“…OBJECTIVETo update the 2001 American Academy of Neurology (AAN) guideline on mild cognitive impairment (MCI). METHODSThe guideline panel systematically…”
Get full text

Research criteria for the diagnosis of prodromal dementia with Lewy bodies by McKeith, Ian G., Ferman, Tanis J., Thomas, Alan J., Blanc, Frédéric, Boeve, Bradley F., Fujishiro, Hiroshige, Kantarci, Kejal, Muscio, Cristina, O'Brien, John T., Postuma, Ronald B., Aarsland, Dag, Ballard, Clive, Bonanni, Laura, Donaghy, Paul, Emre, Murat, Galvin, James E., Galasko, Douglas, Goldman, Jennifer G., Gomperts, Stephen N., Honig, Lawrence S., Ikeda, Manabu, Leverenz, James B., Lewis, Simon J.G., Marder, Karen S., Masellis, Mario, Salmon, David P., Taylor, John Paul, Tsuang, Debby W., Walker, Zuzana, Tiraboschi, Pietro

“…The prodromal phase of dementia with Lewy bodies (DLB) includes (1) mild cognitive impairment (MCI), (2) delirium-onset, and (3) psychiatric-onset…”
Get full text

International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update by Narayanaswami, Pushpa, Sanders, Donald B., Wolfe, Gil, Benatar, Michael, Cea, Gabriel, Evoli, Amelia, Gilhus, Nils Erik, Illa, Isabel, Kuntz, Nancy L., Massey, Janice, Melms, Arthur, Murai, Hiroyuki, Nicolle, Michael, Palace, Jacqueline, Richman, David, Verschuuren, Jan

“…OBJECTIVETo update the 2016 formal consensus-based guidance for the management of myasthenia gravis (MG) based on the latest evidence in the literature…”
Get full text

Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19 by Kanberg, Nelly, Ashton, Nicholas J., Andersson, Lars-Magnus, Yilmaz, Aylin, Lindh, Magnus, Nilsson, Staffan, Price, Richard W., Blennow, Kaj, Zetterberg, Henrik, Gisslén, Magnus

“…OBJECTIVETo test the hypothesis that coronavirus disease 2019 (COVID-19) has an impact on the CNS by measuring plasma biomarkers of CNS injury. METHODSWe…”
Get full text

CNS small vessel disease: A clinical review by Cannistraro, Rocco J, Badi, Mohammed, Eidelman, Benjamin H, Dickson, Dennis W, Middlebrooks, Erik H, Meschia, James F

“…CNS small vessel disease (CSVD) causes 25% of strokes and contributes to 45% of dementia cases. Prevalence increases with age, affecting about 5% of people…”
Get full text

Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies by Fiest, Kirsten M, Sauro, Khara M, Wiebe, Samuel, Patten, Scott B, Kwon, Churl-Su, Dykeman, Jonathan, Pringsheim, Tamara, Lorenzetti, Diane L, Jetté, Nathalie

“…OBJECTIVE:To review population-based studies of the prevalence and incidence of epilepsy worldwide and use meta-analytic techniques to explore factors that may…”
Get full text

A Prospective Study of Neurologic Disorders in Hospitalized Patients With COVID-19 in New York City by Frontera, Jennifer A., Sabadia, Sakinah, Lalchan, Rebecca, Fang, Taolin, Flusty, Brent, Millar-Vernetti, Patricio, Snyder, Thomas, Berger, Stephen, Yang, Dixon, Granger, Andre, Morgan, Nicole, Patel, Palak, Gutman, Josef, Melmed, Kara, Agarwal, Shashank, Bokhari, Matthew, Andino, Andres, Valdes, Eduard, Omari, Mirza, Kvernland, Alexandra, Lillemoe, Kaitlyn, Chou, Sherry H.-Y., McNett, Molly, Helbok, Raimund, Mainali, Shraddha, Fink, Ericka L., Robertson, Courtney, Schober, Michelle, Suarez, Jose I., Ziai, Wendy, Menon, David, Friedman, Daniel, Friedman, David, Holmes, Manisha, Huang, Joshua, Thawani, Sujata, Howard, Jonathan, Abou-Fayssal, Nada, Krieger, Penina, Lewis, Ariane, Lord, Aaron S., Zhou, Ting, Kahn, D. Ethan, Czeisler, Barry M., Torres, Jose, Yaghi, Shadi, Ishida, Koto, Scher, Erica, de Havenon, Adam, Placantonakis, Dimitris, Liu, Mengling, Wisniewski, Thomas, Troxel, Andrea B., Balcer, Laura, Galetta, Steven

“…To determine the prevalence and associated mortality of well-defined neurologic diagnoses among patients with coronavirus disease 2019 (COVID-19), we…”
Get full text

Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study by Bar-Or, Amit, Calkwood, Jonathan C., Chognot, Cathy, Evershed, Joanna, Fox, Edward J., Herman, Ann, Manfrini, Marianna, McNamara, John, Robertson, Derrick S., Stokmaier, Daniela, Wendt, Jeanette K., Winthrop, Kevin L., Traboulsee, Anthony

“…OBJECTIVEThe phase IIIb A Study to Evaluate the Effects of Ocrelizumab on Immune Responses in Participants With Relapsing Forms of Multiple Sclerosis (VELOCE)…”
Get full text

Galcanezumab in chronic migraine: The randomized, double-blind, placebo-controlled REGAIN study by Detke, Holland C, Goadsby, Peter J, Wang, Shufang, Friedman, Deborah I, Selzler, Katherine J, Aurora, Sheena K

“…OBJECTIVETo evaluate the efficacy and safety of galcanezumab, a humanized monoclonal antibody that selectively binds to calcitonin gene-related peptide, in the…”
Get full text

A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers by Jack, Clifford R, Bennett, David A, Blennow, Kaj, Carrillo, Maria C, Feldman, Howard H, Frisoni, Giovanni B, Hampel, Harald, Jagust, William J, Johnson, Keith A, Knopman, David S, Petersen, Ronald C, Scheltens, Philip, Sperling, Reisa A, Dubois, Bruno

“…Biomarkers have become an essential component of Alzheimer disease (AD) research and because of the pervasiveness of AD pathology in the elderly, the same…”
Get full text

Practice guideline update recommendations summary: Disorders of consciousness: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology; the American Congress of Rehabilitation Medicine; and the National Institute on Disability, Independent Living, and Rehabilitation Research by Giacino, Joseph T, Katz, Douglas I, Schiff, Nicholas D, Whyte, John, Ashman, Eric J, Ashwal, Stephen, Barbano, Richard, Hammond, Flora M, Laureys, Steven, Ling, Geoffrey S.F, Nakase-Richardson, Risa, Seel, Ronald T, Yablon, Stuart, Getchius, Thomas S.D, Gronseth, Gary S, Armstrong, Melissa J

“…OBJECTIVETo update the 1995 American Academy of Neurology (AAN) practice parameter on persistent vegetative state and the 2002 case definition on minimally…”
Get full text

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders by Wingerchuk, Dean M, Banwell, Brenda, Bennett, Jeffrey L, Cabre, Philippe, Carroll, William, Chitnis, Tanuja, de Seze, Jérôme, Fujihara, Kazuo, Greenberg, Benjamin, Jacob, Anu, Jarius, Sven, Lana-Peixoto, Marco, Levy, Michael, Simon, Jack H, Tenembaum, Silvia, Traboulsee, Anthony L, Waters, Patrick, Wellik, Kay E, Weinshenker, Brian G

“…Neuromyelitis optica (NMO) is an inflammatory CNS syndrome distinct from multiple sclerosis (MS) that is associated with serum aquaporin-4 immunoglobulin G…”
Get full text

COVID-19 presenting with ophthalmoparesis from cranial nerve palsy by Dinkin, Marc, Gao, Virginia, Kahan, Joshua, Bobker, Sarah, Simonetto, Marialaura, Wechsler, Paul, Harpe, Jasmin, Greer, Christine, Mints, Gregory, Salama, Gayle, Tsiouris, Apostolos John, Leifer, Dana

“…Neurological complications of COVID-19 are not well described. We report two patients who were diagnosed with COVID-19 after presenting with diplopia and…”
Get full text

Blood neurofilament light chain as a biomarker of MS disease activity and treatment response by Kuhle, Jens, Kropshofer, Harald, Haering, Dieter A, Kundu, Uma, Meinert, Rolf, Barro, Christian, Dahlke, Frank, Tomic, Davorka, Leppert, David, Kappos, Ludwig

“…OBJECTIVETo assess the value of blood neurofilament light chain (NfL) as a biomarker of recent, ongoing, and future disease activity and tissue damage and its…”
Get full text